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Summary
Background:  External  counterpulsation  (ECP)  has  been  recognized  as  a  non-invasive  treatment
for chronic  refractory  angina  or  heart  failure.  However,  the  mechanisms  responsible  for  the
clinical beneﬁts  of  ECP  therapy  remain  elusive.  Moreover,  the  clinical  signiﬁcance  of  ECP  therapy
for postoperative  patients  has  not  been  established  yet.
Methods:  Six  adult  patients  received  ECP  therapy  for  60  min  under  pulmonary  artery  catheter
monitoring  after  cardiac  surgery.  Hemodynamic  data  were  obtained  before  ECP  therapy  (pre-
ECP), 20  min  after  ECP  was  commenced  (20-min-ECP),  40  min  after  ECP  was  commenced  (40-
min-ECP), and  after  ECP  therapy  (post-ECP).
Results:  The  mean  right  atrial  pressure  (pre-ECP:  9  ±  4  mmHg;  20-min-ECP:  12  ±  5  mmHg;  40-
min-ECP:  12  ±  4  mmHg;  and  post-ECP:  9  ±  4  mmHg),  pulmonary  wedge  pressure  (16  ±  6  mmHg,
20 ±  7  mmHg,  20  ±  7  mmHg,  and  17  ±  7  mmHg,  respectively),  cardiac  index  (2.4  ±  0.4  l/min/m2,
2.8 ±  0.6  l/min/m2,  2.7  ±  0.5  l/min/m2,  and  2.5  ±  0.4  l/min/m2,  respectively),  cardiac  work
index (2.5  ±  0.4  kg  m/m2,  3.3  ±  0.8  kg  m/m2,  3.1  ±  0.8  kg  m/m2,  and  2.6  ±  0.5  kg  m/m2,  respec-
tively), and  left  ventricular  stroke  work  index  (32  ±  7  g  m/m2,  41  ±  12  g  m/m2,  39  ±  12  g  m/m2,
and 33  ±  8  g  m/m2,  respectively)  signiﬁcantly  (p  <  0.05)  increased  after  ECP  was  commenced
(pre-ECP  vs.  20-min-ECP)  and  decreased  after  ECP  was  discontinued  (40-min-ECP  vs.  post-ECP).
Signiﬁcant  (p  <  0.001)  diastolic  augmentation  (20-min-ECP:  24  ±  6%,  40-min-ECP:  23  ±  5%)  and
systolic unloading  (3  ±  1%,  and  3  ±  1%,  respectively)  were  obtained.  No  clinical  adverse  effects
were observed.
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Conclusions:  ECP  increases  venous  return,  cardiac  output,  and  cardiac  work  in  addition  to  dias-
tolic augmentation  and  systolic  unloading.  These  actions  may  play  important  roles  in  the  clinical
beneﬁts of  ECP  therapy.  Our  data  also  suggest  that  ECP  is  beneﬁcial  for  patients  undergoing
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The  ﬂuid  balance  ranged  between  −226  and  112  ml  (−40  ml
on  average)  and  the  blood  balance  ranged  between  −40  and
65  ml  (−10  ml  on  average)  during  ECP  therapy.  No  adverse
effects,  including  bleeding  problems  or  leg  injuries,  were
Table  1  Patient  characteristics.
Number  of  patients 6
Age  (years)  68  ±  10
Male:female  3:3
Body surface  area  (m2)  1.57  ±  0.17
Diagnosis
Mitral  regurgitation  3
Aortic  valve  disease  2
Coronary  artery  disease  1
Functional  class  (New  York  Heart  Association)
I 2
II 3
III 1
Left ventricular  ejection  fraction 58  ±  7%
Pulmonary  hypertension
None 3
Mild  3
Operationcardiac  surgery.
© 2011  Japanese  College  of  C
Introduction
External  counterpulsation  (ECP)  is  a  non-invasive  treatment
that  utilizes  diastolic  inﬂation  of  a  series  of  lower-extremity
cuffs  to  increase  diastolic  intracoronary  pressure  and  ﬂow.
Simultaneous  cuff  deﬂation  at  the  end  of  diastole  decreases
left-ventricular  afterload.  ECP  was  initially  evaluated  in
patients  with  cardiogenic  shock.  Since  the  advent  of  intra-
aortic  balloon  pumping  (IABP),  IABP  has  been  a  standard  care
for  cardiogenic  shock  or  acute  coronary  syndrome.  On  the
other  hand,  ECP  is  a  non-invasive  treatment,  which  can  be
performed  daily  on  an  outpatient  basis.  Repeated  adminis-
tration  of  ECP,  consisting  of  a  standard  treatment  regimen  of
35  1-h  sessions  over  7  weeks,  has  been  shown  to  have  ben-
eﬁts  in  patients  with  chronic  refractory  angina  [1,2]. ECP
improves  the  angina  class  immediately  after  a  treatment
regimen,  and  these  beneﬁcial  effects  are  mostly  sustained
for  a  few  years  [3].  Moreover,  ECP  therapy  can  be  applied  for
patients  with  chronic  heart  failure  because  ECP  improves  the
quality  of  life  and  functional  classiﬁcation  in  patients  with
mild-to-moderate  heart  failure  [4,5]. However,  the  mech-
anisms  responsible  for  the  clinical  beneﬁt  of  ECP  have  not
been  fully  elucidated  yet.
Moreover,  the  clinical  signiﬁcance  of  ECP  therapy  for
postoperative  patients  has  not  been  established.  In  this
study,  ECP  was  performed  immediately  after  cardiac  surgery.
Patients  generally  have  mild-to-moderate  cardiac  dysfunc-
tion,  due  to  cardioplegic  cardiac  arrest  or  surgical  stress
after  cardiac  surgery.  Patients  commonly  receive  pharma-
cological  treatments,  such  as  catecholamine  administration.
Mechanical  support,  such  as  IABP,  is  a  treatment  option  for
patients  with  low  cardiac  output  syndrome  or  severe  heart
failure.  The  aim  of  the  study  was  to  evaluate  the  hemo-
dynamic  effects  of  ECP  on  postoperative  patients  without
severe  heart  failure.
Methods
Between  July  2009  and  June  2010,  6  patients  were  stud-
ied  (Table  1).  All  6  patients  underwent  ECP  therapy  under
pulmonary  catheter  monitoring  in  the  intensive  care  unit
immediately  after  cardiac  surgery.  No  patients  had  a  surgi-
cal  incision  on  their  legs  or  groins.  Patients  were  intubated
and  sedated.  ECP  was  performed  using  a  Compact  CP  system
(model  NT-CCP,  Nishimura  Kikai  Co.  Ltd.,  Kyoto,  Japan  and
the  University  of  Tokyo,  Tokyo,  Japan).  The  system  proﬁle
has  been  reported  previously  [6].  Brieﬂy,  the  main  feature
of  this  system  is  the  double  lumen  cuff;  the  contact  cuff  is
attached  to  a  leg  with  a  constant  pressure  of  0—10  kPa,  the
main  cuff  is  inﬂated  and  deﬂated  with  a  driving  pressure
of  20—80  kPa.  The  cuff  inﬂation  and  deﬂation  are  synchro-
nized  with  the  patient’s  cardiac  cycle  at  a  ratio  of  2:1.  In
this  study,  the  contact  cuff  pressure  was  set  at  8  kPa  and
the  driving  pressure  at  40  kPa.  Cuffs  were  wrapped  aroundology.  Published  by  Elsevier  Ltd.  All  rights  reserved.
he  patient’s  calves,  thighs,  and  buttocks  and  connected  to
 driving  console  with  an  air  compressor  (Fig.  1).  ECP  was
erformed  for  60  min.  The  radial  artery  pressure  wave  forms
ere  analyzed,  and  peak  or  average  systolic  and  diastolic
ressure  were  obtained  using  a  wave-form  analysis  software
Multi  Trace  CC,  Medical  Try  System  Co.  Ltd.,  Tokyo,  Japan).
ercent  diastolic  augmentation,  percent  systolic  unloading,
nd  diastolic/systolic  pressure  ratio  were  calculated  using
he  equations  shown  in  Fig.  2.  Hemodynamic  data  were
ollected  10  min  before  ECP  commenced  (pre-ECP),  20  min
fter  it  commenced  (20-min-ECP),  40  min  after  ECP  com-
enced  (40-min-ECP),  and  10  min  after  ECP  discontinued
post-ECP).  We  calculated  means  ±  standard  deviation  (SD)
or  continuous  variables  and  compared  them  using  paired
tudent’s  t test.  A  p-value  of  <0.05  was  considered  to  indi-
ate  statistical  signiﬁcance.  The  ethics  committee  approved
ur  study,  and  written  informed  consent  was  obtained  from
ach  patient.
esults
ll  patients  were  transferred  from  the  operating  room  with-
ut  critical  heart  failure  or  low  output  syndrome.  About
 h  later,  ECP  therapy  was  commenced.  During  the  treat-
ent,  the  patients  were  on  a  ﬁxed  dosage  of  dopamine
1—3  g/kg/min)  and  nitroglycerin  (0.3—1.4  g/kg/min).Mitral  valve  repair  /replacement  3
Aortic  valve  replacement 2
Coronary  artery  bypass  1
86  
Figure  1  External  counterpulsation  performed  in  the  inten-
sive care  unit  immediately  after  cardiac  surgery.  Cuffs  are
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monary  capillary  wedge  pressure  signiﬁcantly  increased
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prapped  around  the  patient’s  calves,  thighs,  and  buttocks  and
re connected  to  an  air  compressor  with  tubes.
bserved  during  or  after  ECP  therapy.  The  patients  were
xtubated  within  a  few  hours  after  ECP  therapy.
During  ECP  therapy  (Fig.  3),  the  diastolic/systolic  pres-
ure  ratio  signiﬁcantly  increased  with  signiﬁcant  diastolic
ugmentation  and  systolic  unloading.  The  diastolic/systolic
ressure  ratio  calculated  from  peak  pressure  was  0.85  and
rom  mean  pressure  was  0.87—0.89  on  average.  Mean  arte-
ial  (systemic)  pressure,  mean  pulmonary  pressure,  right
trial  pressure,  pulmonary  capillary  wedge  pressure,  car-
iac  index,  stroke  volume  index,  cardiac  work  index,  left
nd  right  ventricular  work  index,  and  left  and  right  ventric-
lar  stroke  work  index  signiﬁcantly  increased  after  ECP  was
ommenced  (pre-ECP  vs.  20-min-ECP)  and  decreased  after
CP  was  discontinued  (40-min-ECP  vs.  post-ECP).  Systolic
ystemic  vascular  resistance  index,  which  was  calculated
S2mean − right  atrial  pressure)  ×  79.92/cardiac  index,  sig-
iﬁcantly  (p  =  0.003)  decreased  after  ECP  was  commenced,
hile  the  systemic  and  pulmonary  vascular  resistance  index
emained  relatively  constant  (Tables  2  and  3).
d
l
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igure  2  External  counterpulsation  applied  at  a  ratio  of  2:1.  An  ar
ystolic unloading;  D1peak,  peak  diastolic  pressure  with  diastolic  augm
2peak,  peak  diastolic  pressure  without  diastolic  augmentation;  S1m
ean diastolic  pressure  with  diastolic  augmentation;  S2mean,  mean  s
ressure without  diastolic  augmentation.T.  Shimizu  et  al.
iscussion
ike  IABP,  ECP  provides  diastolic  augmentation  and  sys-
olic  unloading.  Unlike  IABP,  ECP  enhances  venous  return
y  squeezing  the  venous  system  [7].  Therefore,  the  pri-
ary  concern  of  the  initial  investigators  was  that  increased
enous  return  during  ECP  therapy  could  precipitate  pul-
onary  edema  in  patients  with  left  ventricular  dysfunction.
owever,  it  has  been  reported  that  ECP  therapy  is  safe  and
ffective  in  angina  patients  with  severe  left  ventricular  sys-
olic  dysfunction  with  an  ejection  fraction  less  than  0.35
8].  Moreover,  the  Prospective  Evaluation  of  Enhanced  Exter-
al  Counterpulsation  in  Congestive  Heart  Failure  (PEECH)
rial  [4]  demonstrated  that  ECP  improves  exercise  toler-
nce,  quality  of  life,  and  functional  classiﬁcation  without  an
ccompanying  increase  in  peak  oxygen  consumption  (VO2)
n  patients  with  ischemic  or  non-ischemic  heart  failure.
ubgroup  analysis  of  the  PEECH  trail  found  that  ECP  has
 beneﬁcial  effect  in  older  patients  with  chronic,  stable,
nd  mild-to-moderate  heart  failure  with  an  accompanying
ncrease  in  peak  VO2 [5].
However,  the  mechanisms  responsible  for  the  clinical
eneﬁts  associated  with  ECP  therapy  have  not  been  fully
lucidated.  Recent  evidence  suggests  that  ECP  may  improve
ymptoms  through  various  mechanisms.  One  of  these  possi-
le  mechanisms  is  promotion  of  myocardial  collateralization
ia  opening  preformed  collateral  vessels,  arteriogenesis,
nd  angiogenesis  by  increasing  coronary  ﬂow  [9].  This  could
e  a  contributing  factor  to  reduced  ischemia  and  improved
yocardial  perfusion  in  angina  patients  with  or  without  left
entricular  dysfunction.  Additionally,  ECP  is  also  associated
ith  improved  diastolic  ﬁlling  and  decreased  plasma  brain
atriuretic  peptide  levels  in  patients  with  stable  coronary
rtery  disease  [10]. This  could  be  another  contributing  fac-
or  to  improved  symptoms  in  patients  with  chronic  heart
ailure.
In  this  study,  right  atrial,  pulmonary  artery,  and  pul-uring  ECP,  resulting  in  increased  cardiac  output.  We  calcu-
ated  cardiac  work  and  demonstrated  that  the  cardiac  work
ndex,  including  the  left  and  right  ventricular  work  index,
row  shows  cuff  inﬂation.  S1peak,  peak  systolic  pressure  without
entation;  S2peak,  peak  systolic  pressure  with  systolic  unloading;
ean,  mean  systolic  pressure  without  systolic  unloading;  D1mean,
ystolic  pressure  with  systolic  unloading;  D2mean,  mean  diastolic
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Figure  3  Pressure  wave  forms  during  external  counterpulsation  with  2:1  assist  ratio.  A  64  year-old  patient  underwent  external
counterpulsation  after  mitral  valve  plasty  (%DApeak 31,  %SUpeak 5,  D/Speak 0.92,  %DAmean 22,  %SUmean 8,  D/Smean 1.00,  see  Fig.  2  for
abbreviations).
Table  2  Systolic  and  diastolic  pressure  and  external  counterpulsation  (ECP).
Pre-ECP 20  min-ECP p 40  min-ECP Post-ECP  p
Peak  pressure
Peak  systolic  pressure
without  systolic  unloading
(S1peak:  mmHg)
130 ±  14  144 ±  16  0.003  140  ±  20  128  ±  15  0.026
Peak diastolic  pressure
with  diastolic
augmentation  (D1peak:
mmHg)
92 ±  11  118 ±  13  <0.001  114 ±  15  91 ±  13  <0.001
Peak systolic  pressure
with  systolic  unloading
(S2peak:  mmHg)
130  ±  14  140  ±  17  0.019  135  ±  20  128  ±  15  0.126
Peak diastolic  pressure
without  diastolic
augmentation  (D2peak:
mmHg)
93  ±  11  95  ±  14  0.248  93  ±  15  90  ±  13  0.452
%diastolic augmentation  −0.7  ±  1.9%  24.2  ±  6.2%  <0.001  23.3  ±  5.4%  0.2  ±  1.5%  <0.001
%systolic unloading  −0.1  ±  1.0%  3.4  ±  1.4%  <0.001  3.2  ±  1.1%  −0.1  ±  0.6%  <0.001
Diastolic/systolic
pressure ratio
(D1peak/S2peak)
0.71  ±  0.03  0.85  ±  0.06  <0.001  0.85  ±  0.07  0.70  ±  0.05  <0.001
Mean pressure
Mean  arterial  pressure  93  ±  11  103  ±  14  0.004  100  ±  14  90  ±  11  0.013
Mean systolic  pressure
without  systolic  unloading
(S1mean:  mmHg)
109  ±  13  123  ±  16  0.005  119  ±  18  107  ±  13  0.026
Mean diastolic  pressure
with  diastolic
augmentation  (D1mean:
mmHg)
97  ±  14  102  ±  13  <0.001  81  ±  11  83  ±  10  0.002
Mean systolic  pressure
with  systolic  unloading
(S2mean:  mmHg)
108  ±  12  114  ±  15  0.022  112  ±  18  105  ±  12  0.158
Mean diastolic  pressure
without  diastolic
augmentation  (D2mean:
mmHg)
82  ±  10  86  ±  13  0.054  83  ±  12  80  ±  11  0.181
%diastolic augmentation  0.7  ±  0.6%  18.2  ±  3.3%  <0.001  16.7  ±  2.0%  1.3  ±  1.4%  <0.001
%systolic unloading  1.1  ±  1.8%  7.3  ±  1.0%  0.001  5.4  ±  2.3%  0.9  ±  1.4%  0.008
Diastolic/systolic
pressure ratio
(D1mean/S2mean)
0.77  ±  0.05  0.89  ±  0.06  <0.001  0.87  ±  0.07  0.77  ±  0.05  0.001
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Table  3  Hemodynamic  change.
Pre-ECP  20  min-ECP  p  40  min-ECP  Post-ECP  p
Heart  rate  (beats/min)  79  ±  11  80  ±  9  0.660  79  ±  8  78  ±  7  0.731
Mean pulmonary  artery
pressure  (mmHg)
16  ±  6  20  ±  7  0.031  20  ±  7  17  ±  7  0.003
Pulmonary capillary  wedge
pressure  (mmHg)
9  ±  3  12  ±  5  0.026  12  ±  4  9  ±  4  0.010
Right atrial  pressure 7 ±  4  9  ±  5  0.037  9  ±  4  7  ±  5  0.009
Cardiac index  (l/min/m2)  2.4 ±  0.4  2.8 ±  0.6  0.041  2.7  ±  0.5  2.5  ±  0.4  0.043
Stroke volume  index
(ml/m2)
31 ±  7  36 ±  10  0.037  35  ±  9  32  ±  7  0.108
Systemic vascular  resistance
index  (dynes  sec/cm5/m2)
2958  ±  921  2788  ±  900  0.179  2750  ±  786  2760  ±  617  0.918
Pulmonary vascular
resistance  index
(dynes  sec/cm5/m2)
238  ±  129  232  ±  146  0.833  235  ±  148  268  ±  148  0.155
Cardiac work  index
(kg m/m2)
2.8  ±  0.4  3.6  ±  0.8  0.018  3.4  ±  0.9  2.8  ±  0.5  0.029
Left ventricular  work  index
(kg  m/m2)
2.7  ±  0.3  3.5  ±  0.7  0.016  3.3  ±  0.8  2.7  ±  0.5  0.026
Left ventricular  stroke  work
index  (g  m/m2)
35  ±  7  44  ±  12  0.025  42  ±  13  35  ±  9  0.050
Right ventricular  work  index
(kg m/m2)
0.30 ±  0.07  0.40  ±  0.11  0.021  0.40  ±  0.09  0.36  ±  0.09  0.017
Right ventricular  stroke
work  index  (g  m/m2)
3.8 ±  0.7  5.0 ±  1.0  0.016  5.0  ±  0.9  4.6  ±  1.0  0.029
Systolic systemic  vascular
resistance  index  without
systolic  unloading
(dynes  sec/cm5/m2)
3526  ±  1095  3364  ±  1044  0.289  3294  ±  847  3314  ±  680  0.850
Systolic systemic  vascular
resistance  index  with
systolic  unloading
(dynes  sec/cm5/m2)
3477  ±  1049  3102  ±  978  0.003  3114  ±  885  3277  ±  641  0.259
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sECP, external counterpulsation.
igniﬁcantly  increased  during  ECP  therapy.  Cardiac  afterload
igniﬁcantly  decreased  immediately  after  cuff  deﬂation  as
 result  of  systolic  unloading,  while  systolic  blood  pressure
ncreased  mainly  caused  by  an  increase  in  cardiac  output.
hese  results  obtained  from  our  study  are  mostly  consis-
ent  with  previous  investigations.  Werner  and  associates  [11]
howed  that  during  ECP  therapy,  there  was  an  augmentation
n  ﬂow  volume  in  the  carotid,  renal,  and  hepatic  arteries
rom  20%  to  25%  and  in  the  coronary  arteries  from  20%  to
0%,  as  well  as  a  12%  increase  in  stroke  volume,  using  duplex
canning  and  echocardiography.
Taguchi  et  al.  [12]  compared  the  hemodynamic  effects
f  IABP  and  enhanced  external  counterpulsation  (EECP,
asomedical  Co.  Ltd.,  NY,  USA)  and  reported  that  right  atrial
ressure,  pulmonary  capillary  wedge  pressure,  and  cardiac
utput  signiﬁcantly  increased  during  ECP  treatment  while
o  signiﬁcant  change  was  observed  in  the  IABP  group.  They
lso  reported  that  the  areas  under  arterial  pressure  during
ystole  did  not  signiﬁcantly  change  during  ECP.  We  speculate
hat  the  left  ventricular  work  index,  which  was  not  calcu-
ated  in  their  study,  might  have  increased  during  their  ECP
herapy.  Because  left  ventricular  work  is  calculated  by  the
l
c
troduct  of  cardiac  output  and  the  difference  between  mean
rterial  pressure  and  pulmonary  capillary  wedge  pressure.
lood  pressure  during  ECP  generally  depends  on  the  condi-
ions;  some  studies  [13]  reported  its  increase,  others  [12,14]
eported  no  signiﬁcant  difference.
These  hemodynamic  changes  observed  during  ECP  ther-
py  are  similar  to  those  observed  during  mild  physical
xercise.  Exercise  training  improves  exercise  capacity,
unctional  class,  quality  of  life  [15], and  survival  [16]
n  patients  with  chronic  heart  failure  or  angina.  The
echanisms  responsible  for  the  clinical  beneﬁts  of  exer-
ise  training  involve  both  central  and  peripheral  effects,
uch  as  improved  endothelial  function,  reduced  peripheral
esistance,  and  improved  diastolic  ﬁlling  [17]. Similar  mech-
nisms  have  been  reported  in  ECP  therapy  [5,10,18,19].
choa  and  colleagues  [14]  found  that  VO2 at  rest  was
ncreased  to  the  same  degree  during  an  ECP  treatment  ses-
ion.  Their  results  suggested  that  the  simulation  of  a  very
ow  level  of  exercise  by  ECP  might  promote  increased  exer-
ise  tolerance  and  improved  clinical  beneﬁts.
Increased  cardiac  output  is  associated  with  increased  sys-
emic  arterial  shear  stress  [18]  and  release  of  nitric  oxide
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REffect  of  external  counterpulsation  on  cardiac  work  
from  endothelial  cells  [19]. Improved  endothelial  func-
tion  is  associated  with  relaxation  of  underlying  vascular
smooth  muscle  [20]. Consequently,  ECP  improves  arterial
stiffness  [21]  and  peripheral  artery  ﬂow-mediated  dilatation
[22].  Moreover,  a  35-h  course  of  ECP  improves  hypertension
[23,24].  These  data  suggest  that  the  daily  acute  effect  of
ECP  can  cause  chronic  vasodilation  and  cardiac  afterload
reduction.  Therefore,  cardiac  work  will  be  decreased  after
the  completion  of  ECP  treatment,  although  the  cardiac  work
is  increased  during  a  60-min  ECP  treatment.  We  also  believe
that  ECP  is  unlikely  to  cause  ischemia,  even  in  increased
myocardial  oxygen  consumption,  because  coronary  ﬂow  was
also  increased  by  diastolic  augmentation.  In  contrast,  phys-
ical  exercise  does  not  provide  diastolic  augmentation  and
systolic  unloading.  Therefore,  ECP  is  particularly  beneﬁcial
in  patients  with  ischemic  cardiomyopathy  and  muscle  weak-
ness,  paralysis  or  extremely  decreased  activities  of  daily
living.
ECP  can  also  be  a  treatment  option  for  postoperative
heart  failure  after  cardiac  surgery  or  other  acute  heart  dis-
eases.  However,  the  signiﬁcance  of  ECP  for  acute  heart
failure  or  acute  coronary  syndrome  has  not  been  estab-
lished  yet.  Cohen  et  al.  [13]  applied  ECP  to  10  patients
with  unstable  angina,  acute  myocardial  infarction,  or  car-
diogenic  shock  and  showed  the  safety  and  feasibility  of  ECP
therapy  in  these  patients.  In  our  study,  the  right  atrial  and
pulmonary  capillary  wedge  pressure  mildly  increased  dur-
ing  ECP.  The  increase  in  cardiac  preload  resulted  in  10—20%
increased  cardiac  output.  Signiﬁcant  diastolic  augmenta-
tion  and  systolic  unloading  were  observed.  These  effects
could  have  been  beneﬁcial  for  the  studied  patients  although
they  had  no  critical  symptoms  of  heart  failure.  Addition-
ally,  as  systolic  blood  pressure  tends  to  increase  during  ECP,
administration  of  a  vasodilator  may  be  helpful  for  reduc-
ing  systolic  blood  pressure  during  ECP  therapy.  In  case  of
critical  myocardial  ischemia  or  decompensated  heart  fail-
ure,  increased  cardiac  preload  or  work  may  cause  adverse
effects  on  patients  undergoing  ECP  therapy  despite  signiﬁ-
cant  diastolic  augmentation.  For  these  patients,  IABP  should
be  indicated.
From  the  other  point  of  view,  ECP  may  be  useful  for
patients  undergoing  cardiac  surgery.  Because  ECP  mildly
increases  cardiac  work  and  VO2 with  an  accompanying
increase  in  coronary  ﬂow,  ECP  can  be  performed  as  part
of  postoperative  cardiac  rehabilitation  protocols.  Cardiac
rehabilitation  has  numerous  beneﬁcial  effects  for  postop-
erative  patients  after  cardiac  surgery  [25]. In  addition,
ECP  may  prevent  deep  vein  thrombosis  (DVT)  after  cardiac
surgery  by  intermittent  compression  of  lower  legs  [26]. DVT
is  a  signiﬁcant  complication  after  cardiac  surgery  [27].
This  study  has  several  limitations.  First,  the  number  of
studied  patients  was  small.  Second,  the  basic  design  of  the
ECP  system  used  in  our  study  was  different  from  that  of
the  ECP  system  used  in  the  previous  investigations,  such  as
the  Vasomedical  EECP  mentioned  earlier.  The  Vasomedical
system  consists  of  single-chamber  cuffs.  In  contrast,  our  sys-
tem  has  double-chamber  cuffs,  which  reduce  the  size  of  the
air  compressor  and  the  impact  of  cuff  inﬂation/deﬂation.
Therefore,  the  capacity  of  the  system  compressor  was  lim-
ited.  The  maximum  assist  rate  was  approximately  60/min.
For  this  reason,  we  applied  ECP  in  2:1  ratio,  which  might
have  affected  the  results  of  our  study.89
Third,  ECP  therapy  was  performed  in  about  one  hour  after
ransfer  to  the  ICU  because  patients  were  usually  extubated
n  a  few  hours  postoperatively.  As  most  patients  were  in
he  hyper-diuretic  phase  after  cardiopulmonary  bypass,  we
ften  needed  to  increase  ﬂuid  volume  in  order  to  maintain
he  water  in-out  balance  during  ECP  therapy.  Hypovolemia
ay  reduce  the  effect  of  ECP.  Moreover,  both  low  cardiac
utput  and  hypothermia  are  known  to  increase  systemic  vas-
ular  resistance  after  cardiac  surgery.  Vasoconstriction  may
lso  reduce  the  effect  of  ECP.  Indeed,  the  D/S  ratio  obtained
n  this  study  was  relatively  less  than  that  obtained  in  our  pre-
ious  pilot  study  [6].  The  response  to  ECP  may  be  reduced
n  perioperative  periods  in  some  patients.
Fourth,  patients  undergoing  coronary  artery  bypass  are
enerally  considered  to  be  good  candidates  for  postopera-
ive  ECP  therapy.  However,  they  are  often  excluded  because
f  a  lower  leg  incision.  Finally,  the  ECP  system  is  basically
esigned  for  out-patient  treatments,  with  each  treatment
eriod  limited  to  1  or  2  h.  It  is  possible  that  longer  or  more
ontinuous  treatment  might  be  feasible  for  the  treatment
f  acute  heart  ischemia  or  failure.
In  conclusion,  ECP  increases  venous  return  and  cardiac
utput  during  counterpulsation  in  addition  to  diastolic  aug-
entation  and  systolic  unloading.  Consequently,  cardiac
ork  load  increases  during  ECP  therapy.  These  acute  actions,
hich  are  rare  in  intra-aortic  balloon  pumping,  may  play
mportant  roles  in  the  clinical  beneﬁts  of  ECP  therapy,  espe-
ially  in  patients  with  chronic  ischemia  or  heart  failure.
ur  data  also  suggest  that  ECP  is  effective  in  patients  with
ild-to-moderate  acute  heart  failure  or  ischemia  following
ardiac  surgery.  Moreover,  ECP  may  be  performed  as  part  of
ostoperative  cardiac  rehabilitation.  Further  investigations
re  needed  to  conﬁrm  the  signiﬁcance  of  ECP  therapy  for
uch  patients.
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